Search for Clinical Trial Results
Amyloidosis - 257 Studies Found
Status | Study |
Completed |
Study Name: Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma Date: 2008-11-12 Interventions:
|
Active, not recruiting |
Study Name: Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis Condition: Primary Amyloidosis Date: 2012-10-11 Interventions: Drug: NEOD001 Monoclonal antibody administered by intravenous infusion every 28 days. |
Active, not recruiting |
Study Name: S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis Condition:
Date: 2003-07-08 Interventions:
|
Recruiting |
Study Name: Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial Condition: Primary Systemic Amyloidosis Date: 2014-07-23 Interventions: Drug: Doxycycline Doxycycline will be continued until one |
Completed |
Study Name: Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis Condition:
Interventions: |
Active, not recruiting |
Study Name: A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis Condition:
Date: 2013-02-06 Interventions:
|
Completed |
Study Name: 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 1999-11-01 Interventions: Drug: 4'-iodo-4'-deoxydoxorubicin |
Completed |
Study Name: Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2007-11-28 Interventions:
|
Completed |
Study Name: High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2004-08-04 Interventions:
|